Related Experiment Videos
Identification of novel L1CAM mutations using fluorescence-assisted mismatch analysis
P Saugier-Veber1, C Martin, N Le Meur
1Laboratoire de Génétique Moléculaire, CHU de Rouen, France.
Human Mutation
|September 23, 1998
Summary
Fluorescent Assisted Mismatch Analysis (FAMA) enables rapid detection of L1CAM gene mutations. This method aids in diagnosing conditions like hydrocephalus-stenosis of the aqueduct of Sylvius (HSAS) and MASA syndrome for accurate genetic counseling.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- The L1CAM gene, located at Xq28, encodes a neuronal cell adhesion molecule.
- Mutations in L1CAM are associated with HSAS, MASA syndrome, and SPG1, presenting diagnostic challenges due to gene size and mutation heterogeneity.
- Traditional molecular analysis of L1CAM is labor-intensive and complex.
Purpose of the Study:
- To optimize the Fluorescent Assisted Mismatch Analysis (FAMA) method for efficient L1CAM gene mutation detection.
- To establish FAMA as a reliable diagnostic tool for L1CAM-related disorders.
Main Methods:
- The L1CAM gene was divided into nine genomic fragments, each encompassing 3-4 exons.
- Fragments were amplified using PCR with universal primers, followed by a second-stage PCR with dye-labeled primers.
- Generated 1-kb-labeled fragments were analyzed using chemical cleavage analysis (FAMA).
Main Results:
- FAMA successfully identified nine distinct L1CAM mutations in 12 French families with HSAS and/or MASA syndrome.
- Seven of the identified mutations were novel, alongside one intronic variation.
- The optimized FAMA method demonstrated high sensitivity and reliability for mutation scanning.
Conclusions:
- Fluorescent Assisted Mismatch Analysis (FAMA) provides a rapid and dependable method for detecting L1CAM gene mutations.
- This technique is highly suitable for diagnosing HSAS, MASA syndrome, and SPG1, facilitating accurate genetic counseling.
- FAMA significantly improves diagnostic efficiency for families affected by L1CAM-related neurological disorders.